Home

kawasaki disease recurrence, Clarithromycin Plus Intravenous Immunoglobulin Can Reduce the Relapse of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study | Journal the American Heart Association, Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, trial - The Lancet